Is Talaris Therapeutics Inc (TALS) Stock About to Get Hot Monday?

Monday, October 09, 2023 10:55 AM | InvestorsObserver Analysts

Mentioned in this article

Is Talaris Therapeutics Inc (TALS) Stock About to Get Hot Monday?

The market has been down on Talaris Therapeutics Inc (TALS) stock recently. TALS gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Talaris Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on TALS!

See Full TALS Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With TALS Stock Today?

Talaris Therapeutics Inc (TALS) stock has risen 4.07% while the S&P 500 is down -0.55% as of 10:47 AM on Monday, Oct 9. TALS is higher by $0.11 from the previous closing price of $2.70 on volume of 113,833 shares. Over the past year the S&P 500 is up 18.61% while TALS is higher by 16.12%. TALS lost -$1.79 per share in the over the last 12 months. To screen for more stocks like Talaris Therapeutics Inc click here.

More About Talaris Therapeutics Inc

Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders. Click Here to get the full Stock Report for Talaris Therapeutics Inc stock.